510(k) K014084

NYCOCARD CRP CONTROL by Primus Corp. — Product Code DCK

K014084 is an FDA 510(k) premarket notification submitted by Primus Corp. for the device "NYCOCARD CRP CONTROL". The FDA issued a decision of Substantially Equivalent on January 7, 2002. The device falls under product code DCK (C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Primus Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 7, 2002
Date Received
December 11, 2001
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
C-Reactive Protein, Antigen, Antiserum, And Control
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type